Gamboa AC, Gronchi A, Cardona K
A 2024 study led by Wang, Volkow, and colleagues examined two cohorts totaling over 682,000 individuals with either obesity or type 2 diabetes and found the risk of new alcohol use disorder diagnoses was about 50% lower among those taking semaglutide compared to other anti-obesity or diabetes medications (Wang et al., 2024a)
: -
Based on the promising results from this latter pilot study, we recently completed a larger ( n = 182) clinical trial of NAC for PTSD + AUD, which failed to find differences in drinking or PTSD symptom outcomes between NAC and placebo groups (Back et al
Formula contains NO: Gluten, Dairy, Sugar, or Hexane
The X-linked mental retardation gene SMCX/JARID1C defines a family of histone h3 lysine 4 demethylases